Heart shield: cholesterol drug may prevent Chemo-Induced cardiac damage
Prevention
Not yet recruiting
This study tests whether rosuvastatin, a cholesterol-lowering drug, can prevent heart damage in women with breast cancer receiving anthracycline chemotherapy. 400 participants will take either rosuvastatin or a placebo daily for 12 months. The main goal is to see if the drug help…
Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated May 17, 2026 04:33 UTC